Serum response factor and myocardin mediate arterial hypercontractility and cerebral blood flow dysregulation in Alzheimer's phenotype
Open accessThe DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Abstract
Cerebral angiopathy contributes to cognitive decline and dementia in Alzheimer's disease (AD) through cerebral blood flow (CBF) reductions and dysregulation. We report vascular smooth muscle cells (VSMC) in small pial and intracerebral arteries, which are critical for CBF regulation, express in AD high levels of serum response factor (SRF) and myocardin (MYOCD), two interacting transcription factors that orchestrate a VSMC-differentiated phenotype. Consistent with this finding, AD VSMC overexpressed several SRF-MYOCD-regulated contractile proteins and exhibited a hypercontractile phenotype. MYOCD overexpression in control human cerebral VSMC induced an AD-like hypercontractile phenotype and diminished both endothelial-dependent and -independent relaxation in the mouse aorta ex vivo . In contrast, silencing SRF normalized contractile protein content and reversed a hypercontractile phenotype in AD VSMC. MYOCD in vivo gene transfer to mouse pial arteries increased contractile protein content and diminished CBF responses produced by brain activation in wild-type mice and in two AD models, the Dutch/Iowa/Swedish triple mutant human amyloid β-peptide (Aβ)-precursor protein ( APP )- expressing mice and APPsw +/− mice. Silencing Srf had the opposite effect. Expression of SRF did not change in VSMC subjected to Alzheimer's neurotoxin, Aβ. Thus, SRF-MYOCD overexpression in small cerebral arteries appears to initiate independently of Aβ a pathogenic pathway mediating arterial hypercontractility and CBF dysregulation, which are associated with Alzheimer's dementia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Cerebral smooth muscle cells of patients with Alzheimer disease have increased constrictor tone,118 which may contribute to the CBF reduction observed in this condition.100”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Holland, P. M., Abramson, R. D., Watson, R., & Gelfand, D. H. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7276 · Cited by 2,693
Silent Brain Infarcts and the Risk of Dementia and Cognitive Decline
Vermeer, S. E., Prins, N. D., den Heijer, T., Hofman, A., Koudstaal, P. J., & Breteler, M. M. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022066 · Cited by 2,313
Neurovascular regulation in the normal brain and in Alzheimer's disease
Iadecola, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1387 · Cited by 2,213
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Snowdon, D. A. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540340047031 · Cited by 1,590
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Patterns of Brain Activation in People at Risk for Alzheimer's Disease
Bookheimer, S. Y., Strojwas, M. H., Cohen, M. S., Saunders, A. M., Pericak-Vance, M. A., Mazziotta, J. C., & Small, G. W. (2000) · New England Journal of Medicine · doi:10.1056/nejm200008173430701 · Cited by 1,328
(2014) · International Journal of Stroke · doi:10.1111/ijs.12374_18 · Cited by 1,166
O'Brien, J. T., Erkinjuntti, T., Reisberg, B., Roman, G., Sawada, T., Pantoni, L., Bowler, J. V., Ballard, C., DeCarli, C., Gorelick, P. B., et al. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00305-3 · Cited by 1,139
Wang, D.-Z., Chang, P. S., Wang, Z., Sutherland, L., Richardson, J. A., Small, E., Krieg, P. A., & Olson, E. N. (2001) · Cell · doi:10.1016/s0092-8674(01)00404-4 · Cited by 898
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
Snowdon, D. A., Greiner, L. H., Mortimer, J. A., et al. (1997) · PubMed · Cited by 846
Neurovascular mechanisms of Alzheimer's neurodegeneration
Zlokovic, B. V. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.02.001 · Cited by 770
Cerebral hypoperfusion and clinical onset of dementia: the Rotterdam Study
Ruitenberg, A., den Heijer, T., Bakker, S. L. M., van Swieten, J. C., Koudstaal, P. J., Hofman, A., & Breteler, M. M. B. (2005) · Annals of Neurology · doi:10.1002/ana.20493 · Cited by 733
Serum response factor: toggling between disparate programs of gene expression
Miano, J. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(03)00110-x · Cited by 586
Self-citationCasserly, I., & Topol, E. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15900-x · Cited by 560
Myocardin is a master regulator of smooth muscle gene expression
Wang, Z., Wang, D.-Z., Pipes, G. C. T., & Olson, E. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1232341100 · Cited by 540
SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein
Iadecola, C., Zhang, F., Niwa, K., Eckman, C., Turner, S. K., Fischer, E., Younkin, S., Borchelt, D. R., Hsiao, K. K., & Carlson, G. A. (1999) · Nature Neuroscience · doi:10.1038/5715 · Cited by 399
Myocardin: A Component of a Molecular Switch for Smooth Muscle Differentiation
Chen, J., Kitchen, C. M., Streb, J. W., & Miano, J. M. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2086 · Cited by 396
Self-citationDavis, J., Xu, F., Deane, R., Romanov, G., Previti, M. L., Zeigler, K., Zlokovic, B. V., & Van Nostrand, W. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312946200 · Cited by 373
Self-citationDu, K. L., Ip, H. S., Li, J., Chen, M., Dandre, F., Yu, W., Lu, M. M., Owens, G. K., & Parmacek, M. S. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.7.2425-2437.2003 · Cited by 363
Myocardin Is a Key Regulator of CArG-Dependent Transcription of Multiple Smooth Muscle Marker Genes
Yoshida, T., Sinha, S., Dandré, F., Wamhoff, B. R., Hoofnagle, M. H., Kremer, B. E., Wang, D.-Z., Olson, E. N., & Owens, G. K. (2003) · Circulation Research · doi:10.1161/01.res.0000068405.49081.09 · Cited by 356
The serum response factor coactivator myocardin is required for vascular smooth muscle development
Li, S., Wang, D.-Z., Wang, Z., Richardson, J. A., & Olson, E. N. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1233635100 · Cited by 343
Mies, G., Ishimaru, S., Xie, Y., Seo, K., & Hossmann, K.-A. (1991) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.1991.132 · Cited by 335
Amyloid Angiopathy–Related Vascular Cognitive Impairment
Greenberg, S. M., Gurol, M. E., Rosand, J., & Smith, E. E. (2004) · Stroke · doi:10.1161/01.str.0000143224.36527.44 · Cited by 298
Defining the mammalian CArGome
Sun, Q., Chen, G., Streb, J. W., Long, X., Yang, Y., Stoeckert, C. J., & Miano, J. M. (2006) · Genome Research · doi:10.1101/gr.4108706 · Cited by 289
Self-citationRole of the MEOX2 homeobox gene in neurovascular dysfunction in Alzheimer disease
Wu, Z., Guo, H., Chow, N., Sallstrom, J., Bell, R. D., Deane, R., Brooks, A. I., Kanagala, S., Rubio, A., Sagare, A., et al. (2005) · Nature Medicine · doi:10.1038/nm1287 · Cited by 280
Self-citationLocal protein synthesis and its role in synapse-specific plasticity
Martin, K. C., Barad, M., & Kandel, E. R. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00128-8 · Cited by 258
Restricted inactivation of serum response factor to the cardiovascular system
Miano, J. M., Ramanan, N., Georger, M. A., de Mesy Bentley, K. L., Emerson, R. L., Balza, R. O., Xiao, Q., Weiler, H., Ginty, D. D., & Misra, R. P. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406041101 · Cited by 256
Self-citationPark, L., Anrather, J., Zhou, P., Frys, K., Pitstick, R., Younkin, S., Carlson, G. A., & Iadecola, C. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.5207-04.2005 · Cited by 244
Aβ1–40-related reduction in functional hyperemia in mouse neocortex during somatosensory activation
Niwa, K., Younkin, L., Ebeling, C., Turner, S. K., Westaway, D., Younkin, S., Ashe, K. H., Carlson, G. A., & Iadecola, C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.17.9735 · Cited by 244
Beach, T. G., Wilson, J. R., Sue, L. I., Newell, A., Poston, M., Cisneros, R., Pandya, Y., Esh, C., Connor, D. J., Sabbagh, M., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0136-y · Cited by 233
Tong, L., Balazs, R., Thornton, P. L., & Cotman, C. W. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.5463-03.2004 · Cited by 221
Etkin, A., Alarcón, J. M., Weisberg, S. P., Touzani, K., Huang, Y. Y., Nordheim, A., & Kandel, E. R. (2006) · Neuron · doi:10.1016/j.neuron.2006.03.013 · Cited by 218
Control of smooth muscle development by the myocardin family of transcriptional coactivators
Wang, D.-Z., & Olson, E. N. (2004) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.08.003 · Cited by 216
Redwine, J. M., Kosofsky, B., Jacobs, R. E., Games, D., Reilly, J. F., Morrison, J. H., Young, W. G., & Bloom, F. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.242746599 · Cited by 202
Altered brain activation in cognitively intact individuals at high risk for Alzheimer’s disease
Smith, C. D., Andersen, A. H., Kryscio, R. J., Schmitt, F. A., Kindy, M. S., Blonder, L. X., & Avison, M. J. (1999) · Neurology · doi:10.1212/wnl.53.7.1391 · Cited by 194
Functional Organization of Adult Motor Cortex Is Dependent upon Continued Protein Synthesis
Kleim, J. A., Hines, R. M., Calder, K., Pocock, D., VandenBerg, P. M., MacDonald, E., Monfils, M., Sutherland, R. J., & Nader, K. (2003) · Neuron · doi:10.1016/s0896-6273(03)00592-0 · Cited by 171
Midkine Is Regulated by Hypoxia and Causes Pulmonary Vascular Remodeling
Reynolds, P. R., Mucenski, M. L., Le Cras, T. D., Nichols, W. C., & Whitsett, J. A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405254200 · Cited by 163
Cardiomyopathy in transgenic mice with cardiac-specific overexpression of serum response factor
Zhang, X., Azhar, G., Chai, J., Sheridan, P., Nagano, K., Brown, T., Yang, J., Khrapko, K., Borras, A. M., Lawitts, J., et al. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.280.4.h1782 · Cited by 146
Neuronal migration in the murine rostral migratory stream requires serum response factor
Alberti, S., Krause, S. M., Kretz, O., Philippar, U., Lemberger, T., Casanova, E., Wiebel, F. F., Schwarz, H., Frotscher, M., Schütz, G., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501191102 · Cited by 145
Overexpression of stomatin depresses GLUT-1 glucose transporter activity
Zhang, J.-Z., Abbud, W., Prohaska, R., & Ismail-Beigi, F. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.5.c1277 · Cited by 119
Yoshida, T., Kawai‐Kowase, K., & Owens, G. K. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000137190.63214.c5 · Cited by 113
Belaguli, N. S., Zhou, W., Trinh, T.-H. T., Majesky, M. W., & Schwartz, R. J. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4582 · Cited by 106
Chang, J., Wei, L., Otani, T., Youker, K. A., Entman, M. L., & Schwartz, R. J. (2003) · Circulation · doi:10.1161/01.cir.0000084502.02147.83 · Cited by 79
Davis, J., Wagner, M. R., Zhang, W., Xu, F., & Van Nostrand, W. E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301398200 · Cited by 61
Kemp, P. R., & Metcalfe, J. C. (2000) · Biochemical Journal · doi:10.1042/bj3450445 · Cited by 59
Matute‐Bello, G., McDonald, G., Hinds, M., Schoch, H. G., & Crawford, S. W. (1998) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1701225 · Cited by 38
Pharmacology of the mouse-isolated cerebral artery
Bai, N., Moien‐Afshari, F., Washio, H., Min, A., & Laher, I. (2004) · Vascular Pharmacology · doi:10.1016/j.vph.2004.07.001 · Cited by 28
Cationic Polymer and Lipids Augment Adenovirus-Mediated Gene Transfer to Cerebral Arteries In vivo
Toyoda, Ḱ., Nakane, H., & Heistad, D. D. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200109000-00010 · Cited by 27
AKAP12α, an Atypical Serum Response Factor-dependent Target Gene
Streb, J. W., & Miano, J. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412466200 · Cited by 22
Self-citationMiano, J. M. (2004) · Circulation Research · doi:10.1161/01.res.0000140893.16465.2d · Cited by 18
Self-citationDiagnostic criteria for primary progressive mutiple sclerosis: a position paper.
(2000) · Pure Amsterdam UMC · doi:10.1002/1531-8249(200006)47:6 · Cited by 2
Research works printed but not linked: 1
- 10.1002/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8 · doi:10.1002/1531-8249(200006)47:6<739::aid-ana6>3.0.co;2-8
Cited by
Gorelick, P. B., Scuteri, A., Black, S. E., DeCarli, C., Greenberg, S. M., Iadecola, C., Launer, L. J., Laurent, S., Lopez, O. L., Nyenhuis, D., et al. (2011) · Stroke · doi:10.1161/str.0b013e3182299496 · Cited by 3,811
The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
Zlokovic, B. V. (2008) · Neuron · doi:10.1016/j.neuron.2008.01.003 · Cited by 3,280
“Recently, it has been shown that cerebral VSMC in AD individuals have a hypercontractile phenotype that leads to arterial hypercontractility and aberrant responses to vasoactive stimuli (Chow et al., 2007).”
InfluentialNeurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
“Recently, patients with Alzheimer's disease as well as mouse models of this disease with high cerebrovascular levels of serum response factor (SRF) and MYOCD, the two transcription factors that control VSMC differentiation, have been shown to develop a hypercontractile arterial phenotype resulting in brain hypoperfusi…”
BackgroundGlial and neuronal control of brain blood flow
Attwell, D., Buchan, A. M., Charpak, S., Lauritzen, M., MacVicar, B. A., & Newman, E. A. (2010) · Nature · doi:10.1038/nature09613 · Cited by 2,511
“, together with increased contractility of vascular smooth muscle cell”
The Science of Stroke: Mechanisms in Search of Treatments
Moskowitz, M. A., Lo, E. H., & Iadecola, C. (2010) · Neuron · doi:10.1016/j.neuron.2010.07.002 · Cited by 1,930
Metadata
- Authors
- Chow, N., Bell, R. D., Deane, R., Streb, J. W., Chen, J., Brooks, A., Van Nostrand, W., Miano, J. M., & Zlokovic, B. V.
- Affiliations
- *Socratech Research Laboratories L.L.C.,
- Frank P. Smith Laboratories for Neuroscience and Neurosurgical Research, Department of Neurosurgery,
- Cardiovascular Institute Hospital (JP)
- University of Rochester Medicine (US)
- Department of Medicine, Stony Brook University, Stony Brook, NY 11794
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2007-01-16
- Volume
- 104
- Issue
- 3
- Pages
- 823-828
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC1783398
- OpenAlex
- W2113727732
- Cited by
- 209
- References
- 53
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 9 · 2022: 13 · 2021: 12 · 2020: 5 · 2019: 6 · 2018: 7 · 2017: 9 · 2016: 9 · 2015: 14 · 2014: 13 · 2013: 14 · 2012: 13
- FWCI
- 11.14
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (1r43ag024000-01)
- National Institute on Aging (R41AG026950, R37AG023084, R43 AG024000, 1R43 AG 024000, 1R41 AG 026950 01)
- National Heart, Lung, and Blood Institute (HL 62572, R01HL062572)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- Alzheimer's disease, serum response factor, myocardin, vascular smooth muscle cells, cerebral blood flow, cerebral angiopathy, contractile proteins, pial arteries, APP transgenic mice, amyloid-beta, transcription factors, gene transfer, vascular dysfunction
- MeSH terms
- Myocardin, Alzheimer Disease, Animals, Cells, Cultured, Cerebral Arteries, Humans, Mice, Inbred C57BL, Nuclear Proteins, Phenotype, Potassium Chloride, Regional Blood Flow, Trans-Activators, Serum Response Factor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.